Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications
about
Mitochondrial antibodies in primary biliary cirrhosis. I. Localization of the antigen to mitochondrial membranesEpiscleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritisHalothane hepatitis--a preventable disease?Antigenic components of rat connective tissue. 3. Liver connective tissue antigens of rats made cirrhotic by treatment with carbon tetrachloride.Platelet associated immunoglobulins in primary biliary cirrhosis: a cause of thrombocytopenia?Mechanisms of smooth muscle antibody production: a clinical study in children with infections, haemolytic syndromes, and idiopathic thrombocytopenic purpuraAn acquired-pseudo Bernard Soulier syndrome occurring with autoimmune chronic active hepatitis and anti-cardiolipin antibody.Identification and analysis of the major M2 autoantigens in primary biliary cirrhosisDiversity of autoantibodies in patients with antimitochondrial antibody and their diagnostic value.Autoantigens in primary biliary cirrhosisLiver immunology.Chronic active hepatitis.Immune responses to the hepatitis B surface antigen and liver-specific lipoprotein in acute type B hepatitis.Renal tubular acidosis and autoimmune liver disease.Halothane hepatitis.Serum autoantibodies and immunoglobulins in hepatitis-associated antigen (HAA)-positive and -negative liver disease.Paraproteins with antibody activity in acute viral hepatitis and chronic autoimmune liver diseases.Studies on the nature and significance of connective tissue antibodies in adult coeliac disease and Crohn's disease.Chronic hepatitis.Mitochondrial antibodies (AMA)Is mitochondrial antibody diagnostic of primary biliary cirrhosis?Controlled trial of a thymic hormone extract (Thymostimulin) in 'autoimmune' chronic active hepatitis.HLA-DR antigens in primary biliary cirrhosis: lack of associationT-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls.Primary sclerosing cholangitis, the biliary tree, and ulcerative colitis.Duration of chronic active hepatitis and the development of cirrhosisPrimary biliary cirrhosis, presenting as gastrointestinal haemorrhageThe immunology of liver disorders.Familial predisposition to thyroid disease in Down's syndrome: controlled immunoclinical studies.The concept of an 'autoallergic' hepatitis.The significance of gastric antibodies. Clinical and pathological signifance of parietal cell antibodies.Thyroid antibodies and sex-chromosome anomalies.Viral hepatitis related antigens in 'autoimmune' hepatic disorders.Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays.Immunological and histological studies in primary biliary cirrhosisReaction of human smooth muscle autoantibody with gastric parietal cells: a pitfall in the diagnosis of parietal cell autoantibodySerum protein levels in primary biliary cirrhosisActive chronic hepatitis. Part I.Sjögren's syndrome, dysimmunoglobulinaemia and malignant disease.Ulcerative colitis with chronic liver disease, eosinophilia and auto-immune thyroid disease.
P2860
Q24679440-8B3BC190-93DE-4CDC-AE93-634DB5297FBBQ28189406-851E747A-3858-4BB0-A325-96F817EB76FBQ28364794-55F80FF0-9C31-4FE2-9082-44D0C2021455Q30472728-354E2F8E-89E5-465E-B71C-521698FF1215Q33460501-B3E15AFF-957A-4C30-A234-CE16664DA704Q33473471-22420A6C-4B63-4799-AD3D-0283899D6B8DQ33492695-193BCAFD-96D6-42F9-80A3-01CB5555BE66Q33671978-A5B29649-62A6-4812-9EBD-9DB065F7B6F5Q33837601-62711729-0128-4759-B0C7-A5C33D88D1DBQ34111559-7F2083B7-ADF9-4737-B30F-20ADBCDB4D99Q34359990-1609AA33-D14B-463F-A6EB-43C2999BB1A5Q34460416-350978F8-B247-4551-BEFD-5FDCEB07F1FDQ34472722-64C40F4F-EDF8-4551-B196-58F1D0876A16Q34473082-29F89C37-8DB0-4E4F-826B-D0E9A885C06AQ34473342-17E24762-D573-4CF9-AC3A-DC6C060D8CD4Q34476121-5B6A828D-D0F2-4DF9-8D46-CDCBAC17D965Q34476808-46304638-8D51-408B-9B32-B725162B91E8Q34476886-1512097E-4C93-4161-B8E7-70CE11D2FDF9Q34476917-1D14A02C-737C-4A0B-A43F-F702DDF7C3B7Q34477010-91BE3A2D-E887-40E3-A012-DDB445EBB7FBQ34493647-D57D9182-B8EA-494D-A3DC-3BC9FC20BA89Q34525275-BF8A349A-720A-4CEF-8362-199E78C48251Q34526923-9B8BFA72-212E-4A27-BABF-96D26F74B2F2Q34985130-964D170B-0AF6-4DF2-AA17-D15B1E3CCBE7Q35003668-25784C21-6628-4A0B-82F0-F89353B453AFQ35118154-98D959AA-73F0-4B5A-98F6-A293B93889D9Q35144641-8E71D1C9-863D-4327-8A35-D8AA25195AA1Q35144914-C6DD202D-F312-47EE-B62D-CD26F19BEAFDQ35232314-CBDF4CA1-F7CC-4CB1-8AC8-E31C87969F28Q35666335-D1CCE4C2-B6D8-43CC-9F23-553FC448161AQ35859421-CB61F62C-07C0-4FA9-A0DF-4BF2AFE39009Q35861214-8434606F-A026-4399-8D13-DCCB92C8BF9EQ35933503-12BDC456-B306-4DAC-B23F-613F11FA76E8Q36211824-E814A305-85EF-4733-B298-085B16F40F89Q36554060-71C09197-B2E6-4008-AC05-3281FF8DB7ADQ36611648-56A430C0-88BA-43E6-9954-04B8B1C0C1B8Q36642068-63487ED5-8536-4AE6-90CB-298AA88DF9EAQ36659915-57B2AE78-86C4-4E0F-8ABF-CF3FAAB3E607Q36810476-BCD6FA0B-D9C5-4A3A-84C3-D24D1575B919Q36812014-F58F766B-1579-47AB-AE49-2675B1F79FBC
P2860
Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications
description
1966 nî lūn-bûn
@nan
1966 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1966 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1966年の論文
@ja
1966年論文
@yue
1966年論文
@zh-hant
1966年論文
@zh-hk
1966年論文
@zh-mo
1966年論文
@zh-tw
1966年论文
@wuu
name
Tissue antibodies in primary b ...... nd their clinical implications
@ast
Tissue antibodies in primary b ...... nd their clinical implications
@en
Tissue antibodies in primary b ...... nd their clinical implications
@nl
type
label
Tissue antibodies in primary b ...... nd their clinical implications
@ast
Tissue antibodies in primary b ...... nd their clinical implications
@en
Tissue antibodies in primary b ...... nd their clinical implications
@nl
prefLabel
Tissue antibodies in primary b ...... nd their clinical implications
@ast
Tissue antibodies in primary b ...... nd their clinical implications
@en
Tissue antibodies in primary b ...... nd their clinical implications
@nl
P2093
P2860
P1476
Tissue antibodies in primary b ...... nd their clinical implications
@en
P2093
P2860
P304
P407
P577
1966-07-01T00:00:00Z